ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Quality of life"

  • 2020 American Transplant Congress

    Experiences and Challenges Faced by Organ Transplant Recipients with Donor-Derived Hepatitis C Virus Infection

    K. Prakash1, C. Ramirez-Sanchez1, S. I. Ramirez1, C. Logan1, N. Law1, K. Mekeel2, V. Pretorius2, S. Aslam1

    1Medicine, University of California San Diego, San Diego, CA, 2Surgery, University of California San Diego, San Diego, CA

    *Purpose: Recently, transplantation of organs from viremic donors with hepatitis C virus (HCV-V) has increased. Currently, there is a lack of standardization of consent forms…
  • 2020 American Transplant Congress

    Treatment of Hepatic Encephalopathy in Cirrhotic Patients: Does Rifaximin Prevent Clostridioides Difficile Infection? A Retrospective Analysis

    J. D. Goldman, V. Aleksenko, J. L. Davila, N. A. Muhktar, K. Kowdley

    Swedish Medical Center, Seattle, WA

    *Purpose: Clostridioides difficile infection (CDI) is a major cause of morbidity and mortality and new prevention strategies in high-risk patients are needed. Rifaximin has been…
  • 2020 American Transplant Congress

    A Video Education Intervention to Improve Kidney Transplant Knowledge and Willingness to Complete Transplant Evaluation in Dialysis Patients

    D. A. DuBay1, T. A. Morinelli1, Z. Sutton1, M. Chastain1, T. Thompkins Tindal1, Z. Su2, E. Weeda3, P. Mauldin4, M. Casey1, J. Bian2, D. Taber1, P. K. Baliga1

    1Surgery, Division of Transplant Surgery, Medical University of South Carolina`, Charleston, SC, 2General Internal Medicine, Medical University of South Carolina`, Charleston, SC, 3Clinical Pharmacy-Outcomes Sciences, Medical University of South Carolina`, Charleston, SC, 4General Internal Medicine, Medical University of South Carolina, Charleston, SC

    *Purpose: The Centers for Medicare and Medicaid Services has set a goal of 30% (currently 18.5%) of dialysis patients to be on a transplant (Tx)…
  • 2020 American Transplant Congress

    Using Quality Metrics to Improve Access to Living Donor Kidney Transplantation

    C. Jadlowiec, M. Petrosky, J. Welch, S. Holligan, A. Thorp, S. Wilson, C. Mansour, A. Mathur, K. Reddy, H. Khamash, K. Engholdt

    Mayo Clinic, Phoenix, AZ

    *Purpose: Living donor kidney transplants (LDKT) are an excellent option for patients with kidney disease. Delays in donor evaluations can impact donor satisfaction as well…
  • 2020 American Transplant Congress

    Belatacept Monthly Therapy: Transplant Recipients’ Experience

    S. N. Little1, É. N. Arsenault Knudsen2, D. A. Mandelbrot1

    1Transplant, University of Wisconsin Hospital and Clinics, Madison, WI, 2University of Wisconsin Hospital and Clinics, Madison, WI

    *Purpose: While graft and patient outcomes with belatacept have been relatively well documented, the decision to use belatacept for kidney transplant recipients rests in part…
  • 2020 American Transplant Congress

    Cross-Sectional Survey to Assess Barriers to Medication Adherence in an Urban Transplant Population

    A. Reticker, B. Valdepenas, L. Glauner, O. Piatek, S. Kerns, P. West-Thielke

    University of Illinois, Chicago, IL

    *Purpose: Non-adherence is a strong predictor of post-transplant outcome. Barriers to medication adherence (MA) include the cost and complexity of a medication regimen, education level,…
  • 2020 American Transplant Congress

    Assessment of Deceased Donor Kidney and Liver Surgical Recovery Error Rates

    R. D. Hasz, S. M. West, H. M. Nathan

    Gift of Life Donor Program, Philadelphia, PA

    *Purpose: There is no nationally available data related to the incidence of surgical errors in deceased donor organ recoveries or its impact on organ discard…
  • 2020 American Transplant Congress

    Mindfulness at Methodist – Stress Resiliency Strategies for Patients

    E. Vivian1, H. Oduor2, P. Mantry3

    1Digestive Institute, Methodist Dallas Medical Center, Dallas, TX, 2Transplant Institute, Methodist Dallas Medical Center, Dallas, TX, 3The Liver Institute, Methodist Dallas Medical Center, Dallas, TX

    *Purpose: Stress triggers changes in the brain that make people appear distracted and forgetful. Chronic stress damages DNA, causes excess inflammation in the body, impairs…
  • 2020 American Transplant Congress

    Patient-Reported Outcomes in a Prospective Multicenter Trial of Belatacept-Based CNI- and Corticosteroid-Free Immunosuppression Regimens in Kidney Transplantation: A Prospective Analysis Across Two Years

    J. M. Rohan1, J. Leone2, E. Woodle3, D. Kaufman4, A. Shields5, A. Wiseman6, A. Matas7, P. West-Thielke8, E. King5, R. Alloway3

    1Pediatrics, Children's Hospital of Richmond at Virginia Commonwealth University, Richmond, VA, 2Tampa General, Tampa, FL, 3University of Cincinnati, Cincinnati, OH, 4U Wisconsin, Madison, WI, 5U Cincinnati, Cincinnati, OH, 6U Colorado, Denver, CO, 7U Minnesota, Minneapolis, MN, 8UIC, Chicago, IL

    *Purpose: Previous trials have not examined 2-year longitudinal differences in patient-reported outcomes (PRO) between belatacept (BELA)- and tacrolimus (TAC)-based therapies in adult kidney transplant (KTx)…
  • 2019 American Transplant Congress

    Symptom Burden after Living Donor Kidney Transplant Measured with the Functional Assessment of Cancer Therapy – Kidney Symptom Index is Associated with Worse Transplant Outcomes

    J. Peipert, J. Caicedo-Ramirez, K. Ensor, J. Friedewald, M. Abecassis, D. Cella, D. Ladner, Z. Butt

    Northwestern University, Chicago, IL

    *Purpose: As the FDA and other stakeholders in transplantation look for fit-for-purpose (FFP) patient-reported outcome measures, there is a need to better understand symptom burden…
  • « Previous Page
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • …
  • 21
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences